ERN1 and glioblastoma: Additionally, selective inhibition of IRE1 RNase activity with inactive variants targeting IRE1 kinase and RNase domains (K599A, Y892A, and K907A) increased tumor invasion and/or neovascularization in a glioblastoma xenograft model [154].